128 related articles for article (PubMed ID: 25677590)
1. Applications of PET imaging with radiolabelled choline (11C/18F-choline).
Kirienko M; Sollini M; Lopci E; Versari A; Chiti A
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):83-94. PubMed ID: 25677590
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
4. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
5. [The use of 18F-fluorothymidine and 18F-fluorocholine in imaging with positron emission tomography].
Skoura E; Datseris IE
Hell J Nucl Med; 2010; 13(1):88-90. PubMed ID: 20411184
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of positron emission tomographic tracers for imaging of papillomavirus-induced tumors in rabbits.
Probst S; Wiehr S; Mantlik F; Schmidt H; Kolb A; Münch P; Delcuratolo M; Stubenrauch F; Pichler BJ; Iftner T
Mol Imaging; 2014; 13():. PubMed ID: 24622808
[TBL] [Abstract][Full Text] [Related]
7. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
[No Abstract] [Full Text] [Related]
8. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
9. Non-FDG PET in the practice of oncology.
Caroli P; Nanni C; Rubello D; Alavi A; Fanti S
Indian J Cancer; 2010; 47(2):120-5. PubMed ID: 20448372
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
11. Non FDG PET.
Nanni C; Fantini L; Nicolini S; Fanti S
Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
[TBL] [Abstract][Full Text] [Related]
12. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
[TBL] [Abstract][Full Text] [Related]
14. Fluoromethylcholine PET in recurrent multifocal hepatoma.
Lenzo NP; Anderson J; Campbell A; Morandeau L; De Grado TR
Australas Radiol; 2007 Dec; 51 Suppl():B299-302. PubMed ID: 17991090
[TBL] [Abstract][Full Text] [Related]
15. Novel tracers and their development for the imaging of metastatic prostate cancer.
Apolo AB; Pandit-Taskar N; Morris MJ
J Nucl Med; 2008 Dec; 49(12):2031-41. PubMed ID: 18997047
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
Lodi F; Malizia C; Castellucci P; Cicoria G; Fanti S; Boschi S
Nucl Med Biol; 2012 May; 39(4):447-60. PubMed ID: 22172394
[TBL] [Abstract][Full Text] [Related]
17. Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.
Meyer JP; Probst KC; Westwell AD
J Labelled Comp Radiopharm; 2014 May; 57(5):333-7. PubMed ID: 24692121
[TBL] [Abstract][Full Text] [Related]
18. PET/CT and choline: diagnosis and staging.
Farsad M; Schwarzenböck S; Krause BJ
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):343-53. PubMed ID: 23013664
[TBL] [Abstract][Full Text] [Related]
19. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
[TBL] [Abstract][Full Text] [Related]
20. PET Radiopharmaceuticals for Personalized Medicine.
Sharma S
Curr Drug Targets; 2016; 17(16):1894-1907. PubMed ID: 27440185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
